NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE93595 Query DataSets for GSE93595
Status Public on Jul 01, 2017
Title Acquired resistance with epigenetic alterations under long-term anti-angiogenic therapy for hepatocellular carcinoma
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Anti-angiogenic therapy is initially effective for several solid tumors including hepatocellular carcinoma (HCC); however, they finally relapse and progress, resulting in poor prognosis. We here established in vivo drug-tolerant subclones of human HCC cells by long-term treatment with vascular endothelial growth factor receptor (VEGFR) inhibitor and serial transplantation in immunocompromised mice (total 12 months), and then compared them with the parental cells in molecular and biological features. Gene expression profiles elucidated a G-actin monomer binding protein thymosin β 4 (Tβ4) as one of the genes enriched in the resistant cancer cells relative to the initially sensitive ones. Highlighting epigenetic alterations involved in drug resistance, we revealed that Tβ4 could be aberrantly expressed following demethylation of DNA and active modification of histone H3 at the promoter region. Ectopic overexpression of Tβ4 in HCC cells could significantly enhance sphere-forming capacities and infiltrating phenotypes in vitro, and promote growth of tumors refractory to the VEGFR mutltikinase inhibitor sorafenib in vivo. Clinically, sorafenib failed to improve the progression-free survival in patients with Tβ4-high HCC, indicating that Tβ4 expression could be available as a surrogate marker of susceptibility to this drug. This study suggests that Tβ4 expression triggered by epigenetic alterations could contribute to the development of resistance to anti-angiogenic therapy by the acquisition of stemness, and that epigenetic control might be one of the key targets to regulate the resistance in HCC.
 
Overall design The human HCC cell line HuH7 was obtained from the Human Science Research Resources Bank (Osaka, Japan). Microarray analysis was performed to compare gene expression patterns between the parental (HuH7-F0) and drug-resistant cells (HuH7-F6 and -F12). The expression levels of 119 genes were more than four-fold upregulated in HuH7-F6 cells while those of 2199 genes in HuH7-F12.
 
Contributor(s) Ohata Y, Shimada S, Akiyama Y, Mogushi K, Nakao K, Matsumura S, Aihara A, Mitsunori Y, Ban D, Ochiai T, Kudo A, Arii S, Tanabe M, Tanaka S
Citation(s) 28246302
Submission date Jan 13, 2017
Last update date Mar 25, 2019
Contact name Kaoru Mogushi
E-mail(s) [email protected]
Phone +81-3-5802-1797
Organization name Juntendo University
Department Intractable Disease Research Center
Street address 2-1-1 Hongo
City Bunkyo-ku
State/province Tokyo
ZIP/Postal code 113-8421
Country Japan
 
Platforms (1)
GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Samples (4)
GSM2457317 HuH7-F0 (1)
GSM2457318 HuH7-F0 (2)
GSM2457319 HuH7-F6
Relations
BioProject PRJNA361255

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE93595_RAW.tar 17.8 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap